PDS Biotechnology Corp Proceeds from Issuance of Secured Debt
PDS Biotechnology Corp (PDSB) reported Proceeds from Issuance of Secured Debt of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2024-03-28
- PDS Biotechnology Corp proceeds from issuance of secured debt for the quarter ending 2023-12-31 was $0.00.
- PDS Biotechnology Corp proceeds from issuance of secured debt for the quarter ending 2022-12-31 was $0.00.
- PDS Biotechnology Corp proceeds from issuance of secured debt for the quarter ending 2021-12-31 was $0.00.
- PDS Biotechnology Corp proceeds from issuance of secured debt for the quarter ending 2018-12-31 was $0.00.
- PDS Biotechnology Corp proceeds from issuance of secured debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PDS Biotechnology Corp proceeds from issuance of secured debt for fiscal 2022 was $25.00M.
- PDS Biotechnology Corp proceeds from issuance of secured debt for fiscal 2021 was $0.00.
- PDS Biotechnology Corp proceeds from issuance of secured debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Proceeds from Issuance of Secured Debt 3 month | Proceeds from Issuance of Secured Debt 6 month | Proceeds from Issuance of Secured Debt 9 month | Proceeds from Issuance of Secured Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $25.00M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $25.00M 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $0.00 10-K · filed 2019-02-21 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $5.00M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $5.00M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $5.00M 10-Q · filed 2018-08-01 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $11.02M derived: sum of 2 quarters · filed 2018-03-01 | $11.02M derived: sum of 3 quarters · filed 2018-03-01 | $11.02M 10-K · filed 2018-03-01 |
| 2016-09-30 | $11.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $11.02M derived: sum of 2 quarters · filed 2017-11-01 | $11.02M 10-Q · filed 2017-11-01 | $11.02M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $0.00 10-Q · filed 2017-08-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-03 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $3.00M 10-K · filed 2018-03-01 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $3.00M 10-Q · filed 2016-11-01 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $3.00M 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | $3.00M 10-Q · filed 2016-05-03 | |||
| 2014-12-31 | $3.00M 10-K · filed 2017-03-02 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |